Provided by Tiger Fintech (Singapore) Pte. Ltd.

Iovance Biotherapeutics, Inc.

3.06
-0.0100-0.33%
Post-market: 3.090.0200+0.65%19:24 EDT
Volume:9.65M
Turnover:28.94M
Market Cap:1.00B
PE:-2.38
High:3.09
Open:3.05
Low:2.89
Close:3.07
Loading ...
Nov 04, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 04, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Sep 20, 2019

Correspondence

[Cover]Correspondence
Sep 17, 2019

Correspondence

[Cover]Correspondence
Aug 01, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 01, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 19, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Jul 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 02, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Jun 21, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Jun 11, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 11, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 11, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Jun 11, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 11, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 11, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 11, 2019

Major Issues Report

Current report, items 5.02, 5.03, 5.07, 8.01, and 9.01
Jun 03, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
May 22, 2019

Major Issues Report

Current report, items 8.01 and 9.01
May 16, 2019

Major Issues Report

Current report, items 8.01 and 9.01